TG THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tg Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Tg Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $8.82M.
  • Tg Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $102M.
  • Tg Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $20.6M.
  • Tg Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$193M, a 44.1% increase from 2021.
  • Tg Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$345M, a 26% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $102M $8.82M +$53.5M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $48.4M -$9.27M +$27.7M +74.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $20.6M -$12.5M +$39.6M +76% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$18.9M $115M +$150M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$169M -$44.7M -$5.73M -14.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$163M -$37M +$29.9M +44.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$193M -$52.1M +$40.9M +44% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$234M -$35M +$50.2M +58.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$284M -$38.9M +$38.6M +49.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$322M -$66.9M +$22.3M +25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$345M -$92.9M -$6.17M -7.11% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$339M -$85.1M +$594K +0.69% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$339M -$77.5M -$26.6M -52.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$313M -$89.2M -$39M -77.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$274M -$86.8M -$48.8M -129% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$225M -$85.7M -$24.9M -40.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$200M -$50.8M -$15.3M -43% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$185M -$50.2M -$15.6M -44.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$169M -$38M +$105M +73.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$274M -$60.9M -$26.5M -77.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$247M -$35.5M -$79.9M -180% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$168M -$34.7M +$6.89M +16.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$174M -$143M -$112M -360% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$62.6M -$34.3M -$2.74M -8.69% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$59.9M $44.3M +$72.8M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$133M -$41.6M -$13.9M -50.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$119M -$31M -$7.01M -29.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$112M -$31.6M -$6.66M -26.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$105M -$28.4M -$12.4M -77.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$92.6M -$27.7M -$13.7M -97.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$79M -$24M -$6.39M -36.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$72.6M -$24.9M -$11.1M -80.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$61.5M -$16M +$1.09M +6.36% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$62.6M -$14M +$611K +4.18% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$63.2M -$17.6M +$1.08M +5.78% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 -$64.3M -$13.8M +$3.61M +20.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$67.9M -$17.1M -$5.16M -43.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$62.7M -$14.6M -$7M -92% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$55.7M -$18.7M -$10.7M -135% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$45M -$17.4M -$12.8M -275% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$32.2M -$12M -$5.33M -80.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$26.9M -$7.61M -$3.89M -105% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$23M -$7.98M -$4.29M -116% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 -$18.7M -$4.65M -$1.93M -71.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$16.7M -$6.63M -$3.52M -113% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-24
Q1 2013 -$13.2M -$3.71M +$13.7M +78.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$26.9M -$3.69M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$2.71M +$27.4M +91% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3.1M -$2.81M -945% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$17.4M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 -$30.1M -$29.6M -5740% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$297K +$228K +43.4% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-07
Q3 2010 -$516K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$525K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.